Gibbs R, Chambers A, Hill D
Eur J Clin Invest. 2024; 54 Suppl 2:e14353.
PMID: 39674881
PMC: 11646295.
DOI: 10.1111/eci.14353.
Ku K, Kim C, Kim Y, Kang B, La J, Kang I
J Immunother Cancer. 2024; 12(10).
PMID: 39461881
PMC: 11529582.
DOI: 10.1136/jitc-2024-009449.
Mackin S, Sariol A, Diamond M
Immunol Rev. 2024; 328(1):205-220.
PMID: 39162394
PMC: 11661935.
DOI: 10.1111/imr.13383.
LEstrange-Stranieri E, Gottschalk T, Wright M, Hibbs M
Front Immunol. 2024; 15:1395427.
PMID: 39007135
PMC: 11239442.
DOI: 10.3389/fimmu.2024.1395427.
Bennion K, Liu D, Dawood A, Wyatt M, Alexander K, Abdel-Hakeem M
Nat Commun. 2024; 15(1):5280.
PMID: 38902261
PMC: 11190225.
DOI: 10.1038/s41467-024-49475-8.
The anti-B7-H3 blocking antibody MJ18 does not recognize B7-H3 in murine tumor models.
Nammor T, Frizzell J, Lavoie R, Lucien F
bioRxiv. 2023; .
PMID: 38014341
PMC: 10680724.
DOI: 10.1101/2023.11.15.567261.
C-reactive protein impairs immune response of CD8 T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma.
Jiang J, Peng Z, Wang J, Chen M, Wan Y, Huang H
J Immunother Cancer. 2023; 11(10).
PMID: 37844994
PMC: 10582887.
DOI: 10.1136/jitc-2023-007593.
FcγRIIB expressed on CD8 T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.
Bennion K, Tariq M, Wyatt M, Duneton C, Baecher K, Paulos C
Sci Transl Med. 2023; 15(710):eadd1868.
PMID: 37611081
PMC: 11325091.
DOI: 10.1126/scitranslmed.add1868.
Comparative Analysis of Gene Polymorphism in Pulmonary Sarcoidosis and Tuberculosis.
Typiak M, Rekawiecki B, Rebala K, Dubaniewicz A
Cells. 2023; 12(9).
PMID: 37174624
PMC: 10177102.
DOI: 10.3390/cells12091221.
Activation and regulation of alloreactive T cell immunity in solid organ transplantation.
Duneton C, Winterberg P, Ford M
Nat Rev Nephrol. 2022; 18(10):663-676.
PMID: 35902775
PMC: 9968399.
DOI: 10.1038/s41581-022-00600-0.
Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy.
Osuna-Gomez R, Arqueros C, Galano C, Mulet M, Zamora C, Barnadas A
Cancers (Basel). 2021; 13(24).
PMID: 34944786
PMC: 8699550.
DOI: 10.3390/cancers13246167.
IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells.
Charab W, Rosenberger M, Shivram H, Mirazee J, Donkor M, Shekhar S
Front Immunol. 2021; 12:713704.
PMID: 34447380
PMC: 8383740.
DOI: 10.3389/fimmu.2021.713704.
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.
Gogesch P, Dudek S, van Zandbergen G, Waibler Z, Anzaghe M
Int J Mol Sci. 2021; 22(16).
PMID: 34445651
PMC: 8396266.
DOI: 10.3390/ijms22168947.
Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity.
Baecher K, Ford M
Cancer Immunol Immunother. 2021; 70(12):3397-3404.
PMID: 34241677
PMC: 10992943.
DOI: 10.1007/s00262-021-03004-4.
FcγRIIB is a T cell checkpoint in antitumor immunity.
Farley C, Morris A, Tariq M, Bennion K, Potdar S, Kudchadkar R
JCI Insight. 2021; 6(4).
PMID: 33616086
PMC: 7934918.
DOI: 10.1172/jci.insight.135623.
Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer's disease.
Costa A, Agostini S, Guerini F, Mancuso R, Clerici M, Pandey J
J Transl Med. 2020; 18(1):325.
PMID: 32859213
PMC: 7455989.
DOI: 10.1186/s12967-020-02495-6.
Terminally Differentiated Effector Memory CD8 T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.
Jacquemont L, Tilly G, Yap M, Doan-Ngoc T, Danger R, Guerif P
J Am Soc Nephrol. 2020; 31(4):876-891.
PMID: 32165419
PMC: 7191929.
DOI: 10.1681/ASN.2019080847.
Memory T cell-mediated rejection is mitigated by FcγRIIB expression on CD8 T cells.
Morris A, Pinelli D, Liu D, Wagener M, Ford M
Am J Transplant. 2020; 20(8):2206-2215.
PMID: 32154641
PMC: 7395896.
DOI: 10.1111/ajt.15837.
Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8 T Cell Apoptosis to Limit T Cell Immunity.
Morris A, Farley C, Pinelli D, Adams L, Cragg M, Boss J
Immunity. 2020; 52(1):136-150.e6.
PMID: 31940267
PMC: 7326381.
DOI: 10.1016/j.immuni.2019.12.006.
The Complex Association of FcγRIIb With Autoimmune Susceptibility.
Verbeek J, Hirose S, Nishimura H
Front Immunol. 2019; 10:2061.
PMID: 31681256
PMC: 6803437.
DOI: 10.3389/fimmu.2019.02061.